What is this? SoyLife EXTRA is a soy germ concentrate standardized to 10% isoflavones. Specially selected high-quality soy germs are the starting material for SoyLife EXTRA production. This is different from many isoflavone extracts, which are concentrated from soy molasses, or other materials that result from extensive fractionations. Because SoyLife EXTRA has been produced from [...]

SoyLife® Extra
Effects of soy isoflavones on blood lipids and blood pressure in postmenopausal women
By W. Wong, Baylor College of Medicine, USA. Presented at “Dietary Phytoestrogens: Friend or Foe”, New Orleans, USA, 2001. When estrogen production stops during menopause, it is generally accepted to result in a higher risk of hypercholesterolemia and hypertension in postmenopausal women. Hormone replacement therapy (HRT) can have beneficial effects for these women. It lowers [...]
European Patent Office Upholds Isoflavone Patent
The European Patent Office (EPO) has concluded to uphold the validity of the main application patent for the use of isoflavones in consumer products. This patent is part of a series of Intellectual Properties (IPs) related to isoflavones that covers the use of isoflavones for major health indications. Health ingredients manufacturer Frutarom, with headquarters in [...]
Recent Posts
- Safety aspects of soyfoods and soy isoflavones in men
- Safety of Frutarom`s daidzein rich SoyLife products
- SoyLife Overview
- Soylife, Calcium and Vit D in the prevention of osteoporosis – OPUS study 2004–2007
- SoyLife® Extra
- Soy isoflavone supplementation enhances spatial working memory in Men
- Safety evaluation of SoyLife
- Various doses of soy isoflavones do not modify mammographic density in postmenopausal women
- Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors
- Estrogenic activity of glycitein, a soy isoflavone

